Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Gefitinib × Clear all

NCT06630325 2026-01-07

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Phase 2 Active not recruiting

GastrointestinalGenitourinaryGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT00137761 2009-11-02

Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms